COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
Search
Tech
News
COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
Tech
News
Facebook
Linkedin
Twitter
Youtube
Search
COVID-19
Clinical Microbiology
Environmental Microbiology
Antibiotic Resistance
Bacteria
Viruses
Fungi
About Microbe Musings
Contact
More
Paul Naphtali
Paul Naphtali is a PhD candidate at McMaster University and studies cystic fibrosis respiratory disease driven by bacterial infections. He specializes in the study of Pseudomonas-driven infections with genomics and transcriptomics.
17 articles
COVID-19
The new B.1.1.529 variant and Canada: a COVID-19 development to monitor
Paul Naphtali
-
November 26, 2021
Bacteria
Neutrophil neutralized: A way for pathogens to drive cystic fibrosis airway disease
Paul Naphtali
-
May 14, 2021
Announcements
Blog update!
Paul Naphtali
-
March 30, 2021
Announcements
We are now a part of Science Borealis!
Paul Naphtali
-
January 17, 2021
COVID-19
The UK strain that’s come to Canada – a primer
Paul Naphtali
-
January 12, 2021
COVID-19
PEG and the vaccine: Ensuring safety in SARS-Cov-2 vaccination by monitoring allergic responses
Paul Naphtali
-
December 19, 2020
COVID-19
“Beware the Ides of March”: Tapping into the potential of tracking SARS-Cov-2 outbreaks using sewage
Paul Naphtali
-
November 27, 2020
Bacteria
Pseudo-electricity? No, it’s EET! The real thing!
Paul Naphtali
-
November 6, 2020
1
2
3
Page 2 of 3
Stay on op - Ge the daily news in your inbox
Subscribe